More Good News for Boston Scientific’s Coronary IVL Tech
Boston Scientific reported strong early results from its single‑arm FRACTURE trial of the Seismiq 4CE coronary intravascular lithotripsy (IVL) catheter. Freedom from major adverse cardiac events at 30 days was 93.3%, well above the 86.2% target, and procedural success hit 93.7% versus an 85.8% goal. All patients received stents, there were no deaths, and only one required target‑vessel revascularization. The data are being used to support the company’s regulatory filing for the device, which is not yet FDA‑approved.
How Rwanda Is Using Drones to Improve Health Care
In 2016 Rwanda partnered with Zipline to launch drone ports that deliver blood products to hospitals, turning multi‑hour trips into 15‑60‑minute drops. A Wharton‑led study shows the program cut postpartum hemorrhage deaths by 51% and trauma deaths by 30%, while...
Anthropic’s Mythos Threatens Healthcare Cybersecurity: 6 Updates
Anthropic’s Claude Mythos preview can autonomously discover and exploit zero‑day vulnerabilities across major operating systems and browsers, a leap in AI‑driven cybersecurity. Researchers found thousands of previously unknown flaws before the model’s restricted release, and even users with limited training...
HCA Florida Hospital Names CEO
HCA Healthcare appointed Philip Marchesini as CEO and market lead of HCA Florida Fawcett Hospital in Port Charlotte. Marchesini previously led HCA Florida Northside Hospital and held COO roles at Largo and St. Peterburg facilities. He succeeds Michael Ehrat, who moves...
Emory Launches ED Nurse Residency Program
Emory Decatur Hospital has launched the health system’s first emergency department nurse residency, the inaugural Emergency Nurses Association program in the Atlanta region. The year‑long curriculum blends clinical education, bedside training and mentorship, beginning with a 16‑week orientation that includes...
Re: UK Alcohol Deaths Fall for First Time Since Pandemic, but Experts Highlight “Stark Inequalities”
UK alcohol‑specific deaths fell for the first time since the pandemic, yet they remain above pre‑COVID levels. The decline masks stark socioeconomic gaps: men in the most deprived neighborhoods are four times more likely to die from alcohol than those...
13 Healthcare Organizations Moving to Epic
Epic solidified its dominance in the U.S. acute‑care EHR market in 2024, capturing 42.3% of hospitals and 54.9% of beds. The KLAS report shows the vendor added a record net gain as ten health systems selected Epic for 108 hospitals,...
Virginia Health System Names New Chief Digital Officer
Centra Health announced Sanjeev Sah as its senior vice president and chief digital and information officer, a role that will steer the Virginia‑based system’s IT and digital transformation. Sah, who posted the news on LinkedIn on May 19, brings experience as...
20 Large Health Systems Growing Bigger
Hospital consolidation is gaining momentum after a brief post‑pandemic pause, with large health systems pursuing cross‑state mergers, acquisitions and strategic partnerships. Twenty major systems announced or plan deals this year, ranging from Atrium Health’s combination with WakeMed to Sutter Health’s...
Hospitals Freeze Jobs in April
Hospital employment stalled in April, with the Bureau of Labor Statistics reporting zero net hires— the first flat month since June 2021. Seasonal adjustments modestly added 4,300 positions, but the broader healthcare sector still created 37,000 jobs, driven by nursing...
Brain Scans Reveal How Ibogaine Alters Neural Networks in Veterans with Head Trauma
Researchers at Stanford reported that a single dose of ibogaine, combined with magnesium, produced measurable neurobiological changes in 30 combat veterans with mild‑to‑moderate traumatic brain injury and PTSD. Functional MRI scans revealed sustained increases in cerebral blood flow across the...
Contractors Lined up for Specific New Hospital Programme Jobs
The NHS has earmarked ten contractors for the first £15 bn wave of its New Hospital Programme under the Hospital 2.0 Alliance framework. The list includes Graham for Airedale, Willmott Dixon for Royal Cornwall, Sacyr UK for Frimley Health, and others, with...
Aetna’s Chief Digital and Technology Officer on How the Insurer Is Using AI for Patient Engagement
Aetna, owned by CVS Health, has launched a conversational AI assistant and a condition‑specific product called Care Paths to simplify member navigation of benefits and care. The AI tools provide natural‑language answers, map providers, and suggest next‑best actions, while also...
Address Clinical and IT Needs First to Help Ensure Ambient AI Success
Wendy Charles of the University of Denver and Renee Pratt of the University of North Georgia warn that while ambient AI can dramatically speed clinical documentation, it also raises accuracy and integration challenges. They argue that success hinges on addressing...
EMA Marketing Authorization of New Drugs in April 2026
In April 2026 the European Medicines Agency granted marketing authorizations and CHMP positive opinions for a slate of new therapies spanning infectious disease, neurology, immunology, endocrinology and rare disorders. Merck’s Enflonsia monoclonal antibody reduced RSV‑related hospitalizations by 84% in infants,...
Everyone’s Betting on AI to Solve the Physician Shortage —They’re Solving the Wrong Problem
The U.S. healthcare debate frames physician shortages as a supply issue, prompting more residency slots and medical‑school expansions. Recent McKinsey and Deloitte surveys, however, show that the real constraint is distribution—administrative friction keeps trained doctors from working where needed. About...
Lus Essentials LLC - 728783 - 05/14/2026
The FDA issued a warning letter to Lus Essentials LLC on May 14, 2026 after laboratory analysis revealed that its skin‑treatment products contain high levels of mercury. The agency classified the items as unapproved new drugs and misbranded drugs under...
La Crema De Rebeca - 728782 - 05/14/2026
The FDA issued a warning letter to La Crema De Rebeca after laboratory analysis revealed high mercury levels in its skin‑treatment cream. The agency classified the product as an unapproved new drug and a misbranded drug because its labeling omitted...
JW Nutritional LLC - 722096 - 04/15/2026
The FDA issued a Warning Letter to JW Nutritional LLC after a September 2025 inspection uncovered multiple CGMP violations at its McKinney, Texas facility. The firm failed to perform identity testing on incoming high‑risk components, lacked validated process controls, and...
Harbin Jixianglong Biotech Co., Ltd. - 723330 - 05/01/2026
The FDA issued a warning letter to Harbin Jixianglong Biotech after a November 2025 inspection revealed multiple CGMP violations involving its peptide API manufacturing. The firm repackaged and relabeled semaglutide batches from unapproved suppliers, misbranding the products and failing to...
PolleyMed, LLC - 726018 - 05/14/2026
The FDA issued a warning letter to PolleyMed, LLC for marketing its SaniiSwab™ nasal cleaning product as an unapproved new drug and for misbranding claims of FDA OTC approval. The agency’s review of the company’s website and social‑media content found...
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences - 724881 - 04/29/2026
The FDA issued a warning letter to Dr. Sourav K. Mishra of AIIMS Bhubaneswar for serious violations in a bioequivalence study of doxorubicin hydrochloride liposome injection conducted for Qilu Pharmaceutical. The investigator administered the prohibited CYP3A4 inhibitor aprepitant to all...
The Future of Healthcare Screenings: The Power of Vocal Biomarkers
Vocal biomarkers—AI‑driven analysis of a 40‑second voice sample—are emerging as a rapid, non‑invasive screening tool for conditions ranging from mild cognitive impairment and Alzheimer’s to depression, anxiety, Parkinson’s and multiple sclerosis. Recent studies, including a Japanese trial of 1,461 seniors,...
Teen Temptations Beware: MAHA-Era FDA Gives Vapes, Tanning Beds a Boost
The FDA has authorized its first fruit‑flavored vaping products for adult use while signaling it will not prioritize enforcement against many unauthorized vapes and nicotine pouches still under review. At the same time, the agency withdrew a proposed ban on...
Why AI’s Healthcare Promise Is Stalling
Healthcare providers are amassing massive data streams, yet many struggle to turn that information into actionable insights. Health Catalyst’s Chief Product Officer Robbie Hughes argues that the AI promise stalls because organizations focus on new models instead of solid data...
A Match Made in Heaven: Has Your Blood Collection Tube Been Appropriately Validated with Your Assays?
Blood‑collection tubes are FDA‑cleared in‑vitro diagnostic devices, but their clearance does not confirm compatibility with every clinical assay or analyzer. CLSI guideline GP34‑A places the burden of full validation on manufacturers while laboratories are responsible for verification of tube‑assay combinations....
Bipartisan Bill Aims to Break Pharmacies Away From Health Insurers and PBMs
Congress is reintroducing the Patients Before Monopolies Act, a bipartisan bill that would require health insurers and pharmacy‑benefit managers (PBMs) to divest any pharmacies they own. The legislation is led in the Senate by Elizabeth Warren and Josh Hawley and...
Why some People Skip the Closest Pharmacy—And What that Means for Health Care Deserts
A new study from Cal Poly, published in Risk Analysis, reveals that Americans often skip the nearest pharmacy, choosing locations that match the socioeconomic character of their neighborhoods. While 98% of Los Angeles County residents live within 5 km of a pharmacy,...
FDA Approves First-Ever Gene Therapy For Deafness, Opening Door To New Era
The U.S. Food and Drug Administration has approved the world’s first gene therapy for deafness, targeting the OTOF mutation that blocks sound transmission in the inner ear. In a pivotal trial of 20 children and teens, 80% experienced improved hearing...
SERB to Pay Hansa €110M Upfront for EU Rights to Kidney Transplant Drug
SERB Pharmaceuticals will pay Hansa Biopharma €110 million (≈$119 million) upfront for exclusive rights to Idefirix across Europe, the Middle East and North Africa. The antibody‑cleaving enzyme, conditionally approved for highly sensitized kidney‑transplant patients, generated €18.7 million (≈$20 million) in 2025 sales but has...
PID: 58741 - Pediatric Endocrinology and Diabetes Specialists Charlotte
Advocate Health has opened a dedicated Pediatric Endocrinology and Diabetes clinic in Charlotte, North Carolina. The facility, located at 4501 Cameron Valley Parkway Suite 300, provides specialized hormone and diabetes care for children, with Spanish‑language support. It operates under program ID 7387...
Bayer’s Hyrnuo (Sevabertinib) Gains the US FDA Priority Review for 1L Treatment of HER2-Mutated NSCLC
Bayer’s Hyrnuo (sevabertinib) received FDA priority review for first‑line treatment of adults with locally advanced or metastatic non‑small cell lung cancer (NSCLC) harboring HER2 kinase‑domain activating mutations and no prior systemic therapy. The review follows promising interim data from Cohort F...
The EU’s Rare Disease Lottery: Why Your Treatment Depends on Whether You Live in Ireland, Germany or Malta
Around 36 million Europeans—one in twelve—live with a rare disease, and treatments known as orphan drugs often carry steep price tags. After EMA approval, each member state must conduct its own health‑technology assessment (HTA) and decide reimbursement, creating a “lottery” of...
Hospital at Home: The New Model of Modern Care
Virtual hospitals, or "virtual wards," are delivering hospital‑level care to patients at home by using wearables, AI analytics and remote clinician oversight. Early trials show reduced readmissions and the ability to free up roughly three beds per day, while an...
Five Questions with Leonard M. Lopoo, Author of “Wanting Children: Family-Planning Policies and the Engineering of America’s Population”
Leonard M. Lopoo’s new book *Wanting Children* argues that U.S. family‑planning policy is skewed toward subsidizing contraception for low‑income Americans while ignoring infertility support, a legacy of early eugenicist policies. He introduces “wantedness” as a metric for population policy, emphasizing...
First Healthy Volunteers Receive TRIV-573 Doses in Triveni Bio’s Phase I Trial
Trivena Bio has dosed its first healthy volunteers in a Phase I trial of TRIV‑573, a half‑life‑extended bispecific antibody that simultaneously inhibits kallikreins 5/7 and blocks interleukin‑13. The dual‑target approach is designed to repair the skin barrier while curbing inflammation in moderate‑to‑severe...
Unsatisfactory Paps—Recommendations, Remedies
The third edition of the Bethesda System revises adequacy criteria for cervicovaginal Pap tests, setting specific cellularity thresholds—8,000‑12,000 squamous/metaplastic cells for conventional slides and 5,000 for liquid‑based preparations. Endocervical cells and normal endometrial cells no longer count toward these thresholds,...
New Smart Technology in Wearable Wristband May Detect Cardiac Arrest
A Dutch clinical trial (DETECT‑1b) tested a wrist‑worn photoplethysmography (PPG) device that automatically identifies cardiac arrest. Among 49 participants, the algorithm correctly flagged 92% of induced shockable events, achieving 100% detection for ventricular fibrillation and 90% for pulseless ventricular tachycardia....
Common Asthma Drug May Turn Off Tumor 'Switch' Tied to Immunotherapy Resistance
A Northwestern Medicine study published in Nature Cancer shows that blocking the cysteinyl leukotriene receptor 1 (CysLTR1) with the asthma drug montelukast can reverse immunotherapy resistance in several aggressive cancers. Experiments in mouse models and analyses of human tumor samples demonstrated...
The Operator Led Evolution in European Healthcare M&A: The Rise of Founder Bankers in HealthTech, MedTech, FemTech and Healthcare AI
European healthcare M&A is entering a structural inflection point as founder‑bankers—former entrepreneurs and clinicians—displace traditional bulge‑bracket banks for the majority of mid‑market HealthTech, MedTech, FemTech and AI deals. While large cross‑border mega‑transactions above €500 million still rely on Goldman Sachs or...
Africa CDC Declares Continental Emergency over Ebola Outbreak
Africa CDC has declared a Continental Public Health Emergency in response to the Ebola outbreak affecting the Democratic Republic of Congo and Uganda. The DRC has reported 131 deaths among 513 suspected cases, while Uganda has recorded a single fatality....
WHO Members Reject Proposal to Invite Taiwan to Participate in Annual Assembly
The World Health Assembly in Geneva voted to reject a proposal that would have invited Taiwan to participate as an observer, after China, backed by Pakistan, threatened to block any involvement. Delegates from Palau and other nations argued that excluding...
Survey on the EU Legal Framework for Health Data and Data Driven Health Technologies
The European Commission's DG CNECT, together with PwC EU Services, has launched a targeted survey running from 13 May to 22 May 2026. It seeks practical input from researchers, developers, regulators and other stakeholders on accessing and reusing health data while complying with...
Vaccine Experts Debate Options to Combat Outbreak of Unusual Ebola Strain
The World Health Organization convened a closed meeting of vaccine experts after the Bundibugyo ebolavirus outbreak in the Democratic Republic of the Congo was declared a public‑health emergency. The outbreak has produced roughly 500 suspected cases and more than 130...
Government Launches Major Overhaul of Mental Health Care with Focus on Prevention
The UK government unveiled a "once‑in‑a‑generation" mental health strategy that shifts emphasis from crisis intervention to prevention and early support. The plan allocates £473 million (≈$600 million) over four years for emergency departments, community services and youth hubs, while NHS mental‑health spending...
Saving the NDIS or Shrinking It? History Has a Warning for Mark Butler
Health Minister Mark Butler tabled the National Disability Insurance Scheme Amendment (Securing the NDIS for Future Generations) Bill on May 14, arguing it is essential to shield the program from mounting fiscal strain. The legislation seeks to tighten eligibility, introduce...
Advanced Therapy: How Indonesia Can Escape the Middle-Income Trap
Indonesia stands at a crossroads as chronic disease rates climb and the global biopharma market expands rapidly. Advanced therapy medicinal products—gene, cell and RNA‑based treatments—are moving from futuristic concepts to strategic necessities, with more than 4,000 pipelines and roughly 150...
Maternity Staff Take Legal Action over ‘Hazardous’ Exposure to Nitrous Oxide
More than 100 maternity staff at Basildon Hospital in Essex have filed legal claims after being exposed to hazardous levels of nitrous oxide (Entonox) between 2018 and 2023. An internal report found gas concentrations up to 30 times the legal...
Southland Hospital Upgrades Diagnostic Imaging with New Fluoroscopy System
Southland Hospital in New Zealand has installed a new fluoroscopy system costing about S$994,000 (≈ $735,000 USD). The equipment delivers real‑time imaging at lower radiation levels and doubles as a general X‑ray suite, supporting procedures such as PICC line insertions. By expanding imaging...
Queensland Invests A$11.2 Million To Expand Clinical Trials Capacity And Create Biomedical Jobs
The Queensland Government is committing A$11.2 million (about $7.4 million USD) to expand Clinical Trials Group’s operations, establishing a new Phase 1 clinical trials facility in Brisbane. Backed by the A$180.6 million (≈$119 million USD) Sovereign Industry Development Fund, the project will feature over 40...